Nigeria’s top pharmaceutical companies have recorded their strongest profits in at least five years, driven by the exodus of multinationals, which has created room for local manufacturers to fill the widening supply gap in Africa’s biggest consumer market.
Fidson, MeCure, and May & Baker, the three listed players, saw their combined profit for the nine months to September 2025 grow to N15.77 billion, representing a 127.2 percent rise from the same period last year.
Analysts say the more-than-twofold surge in profits growth is likely d
